<?xml version="1.0" encoding="UTF-8"?>
<p>The beta cells of the pancreas are cells that are extremely susceptible to oxidative stress damage due to hyperglycemia-induced ROS/RNS generation. These cells contain relatively minute quantities of antioxidant enzymes, worsening the risk of oxidative damage in hyperglycemia [
 <xref rid="B33-molecules-25-05546" ref-type="bibr">33</xref>]. Glucotoxicity is the main culprit contributing to advancing beta cell dysfunction or apoptosis by inducing cellular stress. Prevention of ROS generation is a promising approach for delaying glucose-induced beta cell apoptosis [
 <xref rid="B6-molecules-25-05546" ref-type="bibr">6</xref>]. Our data revealed decreased ROS production in RIN-5F cells that were treated with vindoline, methanolic and dichloromethane extract of 
 <italic>C. roseus</italic>. It may be suggested that the antioxidant activities of vindoline and that of the extracts are associated with the inhibition of ROS generation. The observed antioxidant effect of vindoline in beta cells was consistent with the report of Tiong et al. [
 <xref rid="B31-molecules-25-05546" ref-type="bibr">31</xref>], where vindoline prevented ROS production in H
 <sub>2</sub>O
 <sub>2</sub>-induced Î²-TC6 cells. These findings highlight that vindoline may be a therapeutic product that can provide leads in the development of new antidiabetic drugs.
</p>
